loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 84343 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 TRIAMCINOLONE ACETONIDE (2)

filter

01 DELCOR ASSET CORP (2)

filter

01 LOTION;TOPICAL (2)

filter

01 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (2)

URL Supplier Web Content
LOTION;TOPICAL
0.025% **Federal Regis...
KENALOG
USA
84343
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
LOTION;TOPICAL
0.1% **Federal Registe...
KENALOG
USA
84343
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 84343

Looking for CTD TGA MCC DOSSIER APPLICATION 84343 2

19

DELCOR ASSET, based in U.S.A, is a pharmaceutical company.

One of their notable products is TRIAMCINOLONE ACETONIDE, with a corresponding application number 84343 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

DELCOR ASSET's KENALOG LOTION;TOPICAL, medication with 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of TRIAMCINOLONE ACETONIDE.

18

DELCOR ASSET, based in U.S.A, is a pharmaceutical company.

One of their notable products is TRIAMCINOLONE ACETONIDE, with a corresponding application number 84343 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

DELCOR ASSET's KENALOG LOTION;TOPICAL, medication with 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of TRIAMCINOLONE ACETONIDE.

Post Enquiry
POST ENQUIRY